They were randomized to receive either ( i ) esomeprazole IV bolus at a dose of @ mg plus infusion at @ mg/h for @ h and oral placebo every @ h ( IVP group ) , or ( ii ) IV placebo bolus plus infusion for @ h and high-dose oral esomeprazole at a dose of @ mg every @ h ( ORP group ) .